“The Adaptogenic, Soviet Based Military Nootropic”
Fonturacetam Hydrazide appears to be an exciting derivative of Phenylpiracetam, and may indeed possess the same benefits across mood, focus and energy levels.
Phenylpiracetam hydrazide, also known as fonturacetam hydrazide, is a racetam that is a derivative of phenylpiracetam in which the amide group is replaced with a hydrazide group Many biohackers agree that Phenylpiracetam is the strongest nootropic they've ever experienced. It's highly bioavailable and you experience the effects within 30 minutes of taking it. Phenylpiracetam increases concentration, motivation, memory, physical endurance, and tolerance to cold.
It turns out that Phenylpiracetam is very effective in boosting athletic performance. It provides significant stimulatory effects and helps you resist cold. Leading to a ban by the World Anti-Doping Agency (WADA) from use by athletes in the Olympics and other professional sports. Neurohackers report that Phenylpiracetam enhances alertness, focus, memory, and learning. It reduces brain fog. And it provides physical stamina and cold tolerance while combating physical and mental fatigue.
Phenylpiracetam increases the density of acetylcholine (ACh), NMDA, GABA and dopamine receptors in the brain.[vi][vii]More receptors mean more binding sites for neurotransmitters that affect memory formation, cognition, sleep and mood (1).
Phenylpiracetam has been shown in clinical studies to affect Alpha and Beta brain waves. Scientists haven’t quite figured out why it works, but Phenylpiracetam has an ‘anti-convulsive’ action in the brain. They did conclude after one clinical trial, “Phenotropil reduced the frequency of seizures and improved cognitive function in the absence of epileptiform EEG abnormalities (2).
The increase in density of neuroreceptors likely accounts for Phenylpiracetam’s stimulant-like properties. Similar to Ritalin or Adderall, this nootropic increases the effectiveness of dopamine in your brain. Increasing alertness, decision-making capability, and cognition (3).
Researchers in Moscow recruited 400 patients suffering from ischemic stroke. This is the most common type of stroke where blood vessels carrying blood to the brain are blocked by a blood clot. Half of the group received 400 mg of Phenylpiracetam daily for a year. The control group got a placebo. The research team found that the group who received Phenylpiracetam experienced a significant restoration in cognitive function (4).
Activates and increases the number of nicotinic acetylcholine and NMDA receptors in the brain, each of which are believed to be involved in reflex time and reaction time (5).
Phenylpiracetam has been gaining popularity among users of “nootropics”, or “cognitive-enhancing” drugs. Interestingly, phenylpiracetam has recently been banned from use by the Olympics committee due to concerns that it could be abused as a performance enhancer by athletes (6).
SInce it increases physical stamina and provides improved tolerance to cold weather, it appears on the lists of stimulants banned for in-competition use by the World Anti-Doping Agency (7).